| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/16/2009 | WO2007033215A3 Compositions having antiangiogenic activity and uses thereof |
| 04/16/2009 | WO2007011702A3 Use of egfr inhibitors to prevent or treat obesity |
| 04/16/2009 | WO2006130690A3 Methods and compositions for inducing brown adipogenesis |
| 04/16/2009 | WO2006121532A3 Treatment for heart disease |
| 04/16/2009 | WO2006086345A3 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 04/16/2009 | WO2006019637A3 An intelligent nanomedicine integrating diagnosis and therapy |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | WO2005056761A3 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | WO2005040356A3 Mutant p53 protein and uses thereof |
| 04/16/2009 | WO2005021727A3 Isoform-specific targeting of splice variants |
| 04/16/2009 | WO2005016414A3 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 04/16/2009 | US20090099611 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
| 04/16/2009 | US20090099125 Pan cancer oncolytic vectors and methods of use thereof |
| 04/16/2009 | US20090099119 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099118 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/16/2009 | US20090099110 Antiviral oligonucleotides |
| 04/16/2009 | US20090099070 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| 04/16/2009 | US20090099060 Modulation of line-1 reverse transcriptase |
| 04/16/2009 | US20090099037 Genomic Screen for Epigenetically Silenced Genes Associated With Cancer |
| 04/16/2009 | US20090098634 Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/16/2009 | US20090098632 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/16/2009 | US20090098614 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA |
| 04/16/2009 | US20090098599 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 04/16/2009 | US20090098565 MeCP2E1 gene |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098148 High efficiency tissue-specific compound delivery system using streptavadin-protein a fusion protein |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098116 Immunogenic compositions for induction of anti-tumor immunity |
| 04/16/2009 | US20090098100 Hormonally up-regulated, neu-tumor-associated kinase |
| 04/15/2009 | EP2048235A2 Synthetic Mammalian Alpha-N-Acetylglucosaminidase and Genetic Sequences Encoding Same |
| 04/15/2009 | EP2048232A1 Non-replicating paramyxoviridae virus vector |
| 04/15/2009 | EP2048229A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 04/15/2009 | EP2048228A2 Human liver progenitors |
| 04/15/2009 | EP2047867A1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 04/15/2009 | EP2047864A1 Use of rpn2 gene expression inhibitor |
| 04/15/2009 | EP2046950A2 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 04/15/2009 | EP2046394A2 Use of nucleic acid sequences for the treatment of neurological and psychiatric diseases, vectors and compositions |
| 04/15/2009 | EP1931390A4 Compositions and methods for treatment of autoimmune disease |
| 04/15/2009 | EP1390490B1 Muscle-specific expression vectors |
| 04/15/2009 | EP1326969B1 Improved system for regulation of transgene expression |
| 04/15/2009 | EP1325145B1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |
| 04/15/2009 | EP1212446B1 Viral replicons and viruses dependent on inducing agents |
| 04/15/2009 | EP1203007B1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) and its receptor c-met |
| 04/15/2009 | EP1079854B1 Compositions and methods of modulating an immune response to an antigen by administration of cytokine-coated cells |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | CN101407815A Preparing method of glycine-N-methyltransferase (GNMT) knockout mouse model and use thereof |
| 04/15/2009 | CN101407809A Specific inference hog cholera virus genome sequence and method for efficiently curing hog cholera virus infection |
| 04/15/2009 | CN101407796A Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 04/15/2009 | CN100478689C Polypeptide and use thereof |
| 04/15/2009 | CN100478034C A siRNA and expression carrier capable of inhibiting Bax gene expression and application of the same used as virus hepatitis B treatment medicament |
| 04/15/2009 | CN100478033C Medicine comprising HGF gene |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517967 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517866 LIM mineralization protein splice variants |
| 04/14/2009 | US7517865 RNAi modulation of RSV and therapeutic uses thereof |
| 04/14/2009 | US7517864 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517860 Inhibition of lipoprotein secretion |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |
| 04/14/2009 | US7517669 Increasing the intracellular amount of at least one ferritin-H or a derivative to an effective level for suppressing disease caused or enhanced by effects of intracellular iron mismanagement |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517646 Provides functional molecule having an affinity and specificity to a target comparable to the affinity and specificity of an antibody against an antigen; modified oligonucleotide sequence |
| 04/14/2009 | US7517525 Methods of inhibiting amyloid toxicity |
| 04/14/2009 | US7517523 Anti-MIF antibodies |
| 04/14/2009 | US7517521 Transplanting and propagating neuronal stem cells for use as tools in prevention and treatment of nervous system disorders |
| 04/14/2009 | CA2321215C Hybrid adenovirus-aav virus and method of use thereof |
| 04/14/2009 | CA2259657C Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
| 04/14/2009 | CA2230819C Medicament comprising hgf gene |
| 04/14/2009 | CA2208237C Nuclear protein serine/threonine kinases |
| 04/09/2009 | WO2009046464A1 Articular cartilage gene therapy with recombinant vector encoding bmp-7 |
| 04/09/2009 | WO2009046395A2 Method to predict response to treatment for psychiatric illnesses |
| 04/09/2009 | WO2009046346A2 Stem cell therapy for weight loss |
| 04/09/2009 | WO2009046335A1 Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
| 04/09/2009 | WO2009046059A1 Self complementary aav-mediated delivery of interfering rna molecules to treat or prevent ocular disorders |
| 04/09/2009 | WO2009045965A2 Stat5a and its functional tumor suppressor analogs for treatment of malignancies expressing npm/alk and other oncogenic kinases |
| 04/09/2009 | WO2009045545A2 Antidotes for agonistic aptamers |
| 04/09/2009 | WO2009045536A2 Receptor targeted oligonucleotides |
| 04/09/2009 | WO2009045356A2 Microrna compositions in the treatment of vegf-mediated disorders |
| 04/09/2009 | WO2009045308A2 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression |
| 04/09/2009 | WO2009045179A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 04/09/2009 | WO2009044899A1 Nucleic acid capable of regulating the proliferation of cell |
| 04/09/2009 | WO2009044787A1 Remedy for tendon rupture disease comprising tenomodulin as the active ingredient |
| 04/09/2009 | WO2009044392A2 Novel sirna structures |
| 04/09/2009 | WO2009044383A1 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof |
| 04/09/2009 | WO2009044165A2 Molecular adjuvant |
| 04/09/2009 | WO2009043936A1 Widespread gene delivery to motor neurons using peripheral injection of aav vectors |
| 04/09/2009 | WO2009043921A1 Attenuated invasive e. coli strains and applications thereof as intracellular vector for therapeutic molecule |
| 04/09/2009 | WO2009021235A3 Methods and compositions for treating cancer |
| 04/09/2009 | WO2009009591A4 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 04/09/2009 | WO2008157572A3 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 04/09/2009 | WO2008151841A3 Treatment for alzheimer' s disease |
| 04/09/2009 | WO2008144754A3 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases |
| 04/09/2009 | WO2008137758A3 Amino acid lipids and uses thereof |
| 04/09/2009 | WO2008125908A3 Enhanced retinal delivery of a nucleic acid through iontophoresis |
| 04/09/2009 | WO2008121442A3 Pa28-gamma regulation in cells |